Local Institution - 109

Washington D.C., District of Columbia 20007

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) — Stopped early